Minerva Neurosciences | NERV - سرمایه گذاری در بازار





سرمایه گذاری در بازار تغییر دادن تاریخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Adma Biologics USD 3.52B 824M 2026-03
ALKERMES USD 4.47B 146M 2026-03
Alterity Therapeutics Limited AUD 11M 5M 2023-06
AstraZeneca USD 220.14B 68B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.58M 475.91M 2026-03
CSL USD 71.32B 15.44B 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Grifols EUR 2.02B 4.34B 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novavax USD 1.43B 340M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12